Rare diseases
Investigational molecules
Locations
Hugstetter Strasse 55, Stuehlinger, 79106 Freiburg Im Breisgau, Germany
Medical Center - University Of Freiburg in Freiburg Im Breisgau, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Acute myeloid leukaemia, Non-small cell lung cancer, Sjogren's syndrome, and other specialisations. This site conducts important research.
The Klinik für Strahlenheilkunde at the Medical Center – University Of Freiburg conducts cutting‑edge research in radiation oncology, concentrating on aggressive brain tumors such as glioblastoma and astrocytoma.
The site is located in Freiburg Im Breisgau, Germany, supports 7 active clinical studies and involves a team of over 125 investigators dedicated to improving outcomes for patients with malignant brain tumors.
More sites in Freiburg Im BreisgauGermany
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
GermanyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
GermanyA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
GermanyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
GermanyA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
GermanyA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
GermanyLong-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
